Survey of oncohematological pharmaceutical care situation in Spain.

Objective: To learn about the baseline of Oncohematological Pharmacy Units in Spanish hospitals in order to identify areas for  improvement.

Method: A survey in line with the objectives set in GEDEFO 2020  Strategic Plan of Pharmaceutical Care for oncohematological patients  was designed. The survey was hosted on GEDEFO's website during  March and April 2017.

Variability of carboplatin dose calculation methods in Spain.

Objective: To describe and analyze the variability in carboplatin dosing strategies in Spanish hospitals.

Methods: We designed a questionnaire consisting of 19 multiple-choice items structured in two sections (hospital characteristics and carboplatin dosing data). The questionnaire was sent by e-mail to all the oncology pharmacists included in the register of the Spanish Oncology Pharmacy Group (GEDEFO), and we analyzed the completed questionnaires.

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines.

Biological medicines nowadays have a great impact, as they offer treatment for  diverse diseases and suppose a high cost for health system. Biosimilar medicines contain a version of an active substance already authorized as an original  biotechnological medicine, whose patent has expired, and they comply with the  guidelines published by the European Medicines Agency. These guidelines, where biosimilarity criteria are established, guarantee comparability between biosimilar product and reference one.